Our goal is to accelerate and optimize the development of new anticancer agents. To achieve it, we provide research services and expertise in in vitro, ex vivo and in vivo oncology.
We explore the characteristics and effects of your compounds using cutting-edge technologies and our extensive bank of preclinical human and murine tumour models.
Our aim is to support our clients in a go-fast decision and in a cost-effective manner.
Our team and scientific committee are composed of scientists, oncologists and haematologists with international level expertise in onco-pharmacology, providing a strategic vision for short and medium-term development strategies.
Our scientific expertise and our operational reactivity are dedicated to the success of your development.